Endotoxin neutralization with rabbit antisera to Escherichia coli J5 and other gram-negative bacteria
暂无分享,去创建一个
H. S. Warren | G. Siber | S. Kania | T. Novitsky | A. Bucklin | H. Warren
[1] C. Dinarello,et al. Role of interleukin-1 in augmenting serum neutralization of bacterial lipopolysaccharide , 1987, Journal of clinical microbiology.
[2] H. S. Warren,et al. Neutralization and lipoprotein binding of lipopolysaccharides in tolerant rabbit serum. , 1986, The Journal of infectious diseases.
[3] R. Ulevitch,et al. Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum , 1986, The Journal of experimental medicine.
[4] H. S. Warren,et al. Neutralization of bacterial lipopolysaccharides by human plasma , 1985, Journal of clinical microbiology.
[5] H. S. Warren,et al. Turbidimetric method for quantifying serum inhibition of Limulus amoebocyte lysate , 1985, Journal of clinical microbiology.
[6] R. Ulevitch,et al. Control of lipopolysaccharide-high density lipoprotein binding by acute phase protein(s). , 1983, Journal of immunology.
[7] A. Lindberg,et al. Induction of endotoxin tolerance with nonpyrogenic O-antigenic oligosaccharide-protein conjugates , 1983, Infection and immunity.
[8] W. R. Mccabe,et al. Immunization with rough mutants of Salmonella minnesota. IV. Protection by antisera to O and rough antigens against endotoxin. , 1983, The Journal of infectious diseases.
[9] J. McCutchan,et al. TREATMENT OF GRAM-NEGATIVE BACTEREMIA AND SHOCK WITH HUMAN ANTISERUM TO A MUTANT ESCHERICHIA COLI , 1983 .
[10] J. Lipton,et al. Biological activity, lipoprotein-binding behavior, and in vivo disposition of extracted and native forms of Salmonella typhimurium lipopolysaccharides. , 1982, The Journal of clinical investigation.
[11] J. Pennington,et al. Type-specific vs. cross-protective vaccination for gram-negative bacterial pneumonia. , 1981, The Journal of infectious diseases.
[12] J. Boslego,et al. A general approach to standardization of the solid-phase radioimmunoassay for quantitation of class-specific antibodies. , 1981, JIM - Journal of Immunological Methods.
[13] A. Nowotny,et al. Immunization Against Bacteria- and Endotoxin-Induced Hypotension , 1981, Infection and immunity.
[14] R. Ulevitch,et al. New function for high density lipoproteins. Isolation and characterization of a bacterial lipopolysaccharide-high density lipoprotein complex formed in rabbit plasma. , 1981, The Journal of clinical investigation.
[15] C. J. Webster. Principles of a quantitative assay for bacterial endotoxins in blood that uses Limulus lysate and a chromogenic substrate , 1980, Journal of clinical microbiology.
[16] D. Dubose,et al. Comparison of plasma extraction techniques in preparation of samples for endotoxin testing by the Limulus amoebocyte lysate test , 1980, Journal of clinical microbiology.
[17] S. E. Greisman,et al. Experimental gram-negative bacterial sepsis: prevention of mortality not preventable by antibiotics alone , 1979, Infection and immunity.
[18] R. Ulevitch,et al. The modification of biophysical and endotoxic properties of bacterial lipopolysaccharides by serum. , 1978, The Journal of clinical investigation.
[19] S. E. Greisman,et al. Experimental Gram-Negative Bacterial Sepsis: Reevaluation of the Ability of Rough Mutant Antisera to Protect Mice 1 , 1978, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[20] E. Ziegler,et al. Neutralization of meningococcal endotoxin by antibody to core glycolipid , 1978, The Journal of experimental medicine.
[21] P. Ward,et al. Isolation from human serum of an inactivator of bacterial lipopolysaccharide. , 1977, The American journal of pathology.
[22] A. Nowotny,et al. Relationship of structure to function in bacterial endotoxins: serologically cross-reactive components and their effect on protection of mice against some gram-negative infections. , 1976, Journal of general microbiology.
[23] E. Milner,et al. Preparation and properties of a national reference endotoxin , 1976, Journal of clinical microbiology.
[24] L. Young. Opsonizing antibodies, host factors, and the limulus assay for endotoxin , 1975, Infection and immunity.
[25] M. Wilson,et al. Protection Against Gram-Negative Infections with Antiserum to Lipid A from Salmonella minnesota R595 , 1974, Infection and immunity.
[26] E. J. Young,et al. Mechanisms of endotoxin tolerance. 8. Specificity of serum transfer. , 1973, Journal of immunology.
[27] A. Braude,et al. Treatment and prevention of intravascular coagulation with antiserum to endotoxin. , 1973, The Journal of infectious diseases.
[28] G. A. Hébert,et al. Determination of the optimal ammonium sulfate concentration for the fractionation of rabbit, sheep, horse, and goat antisera. , 1973, Applied microbiology.
[29] A. Braude,et al. Passive immunization against the local Shwartzman reaction. , 1972, Journal of immunology.
[30] C. Galanos,et al. Preparation and properties of antisera against the lipid-A component of bacterial lipopolysaccharides. , 1971, European journal of biochemistry.
[31] A. van Dalen,et al. Isolation and some properties of rabbit IgM immunoglobulin. , 1967, Biochimica et Biophysica Acta.
[32] E. J. Young,et al. MECHANISMS OF ENDOTOXIN TOLERANCE , 1966, Journal of Experimental Medicine.
[33] W. W. Wells,et al. PROTECTION AGAINST LETHALITY OF E. COLI ENDOTOXIN WITH “O” ANTISERUM * , 1966, Annals of the New York Academy of Sciences.
[34] F. Rosen,et al. Inactivation of Biologically Active (“Endotoxic”) Polysaccharides by Fresh Human Serum , 1957, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.